Established in 1974
185,800 clients worldwide
Over 15,000 markets

FX levels to watch – GBP/USD, EUR/USD, AUD/USD. USD/CAD

Fed minutes have put markets on notice for a June move, so the losses in EUR/USD look set to continue, while the USD/CAD rally has entered a new phase.

GBP/EUR forex pair
Source: Bloomberg

GBP/USD surges on Brexit news
Yesterday’s Brexit poll, which gave a healthy lead to the ‘Remain’ campaign, was the cue for another surge in cable, with only a modest pullback seen thus far this morning. Three days of gains have turned the pair bullish, so dips should see buying as and when they appear.

The next target is $1.4668, the high from the beginning of the month, while beyond this the 200-day simple moving average (SMA) at $1.4804 still looms.

GBP/USD price chart

EUR/USD seems to have stablised
After heavy losses yesterday the pair has stabilised just above $1.12, but having opened below key support (now resistance) at $1.1223, it looks like further downside is on the way. We may see the pair head towards $1.1149, the 100-day SMA, or to the 200-day SMA at $1.11.

Any rally back towards $1.13 would start to look like a possible selling opportunity. It will need sustained price action back above $1.13 to turn the pair bullish.

EUR/USD price chart

AUD/USD primed to bounce
Rallies continue to be sold, as we saw on Tuesday, but with the pair oversold intraday a bounce back towards $0.73 could be the likely move. The low from the end of February, $0.71, is the next area to watch. 

AUD/USD price chart

USD/CAD in the bull’s hands
FOMC hawkishness has put more life into this rally, with the push above C$1.30 providing fresh bullish sentiment. The next target would be C$1.32, the high from early April, with the 200-day SMA at C$1.3357 the next stopping point. 

USD/CAD price chart

The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication.

Find articles by analysts